28 /100
MEDIUM RISK
Score updated May 30, 2026

GPCR — Structure Therapeutics Inc. Dilution Risk Tracker

Track GPCR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GPCR — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GPCR.
🔔 Track GPCR — Get forecast alerts →

💹 Market Data

Market Cap$2.80B
Shares Outstanding71.07M
FloatN/A
Cash$1.45B
Debt$6.49M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 13.8% shares (2025Q4 vs prior)
199 institutional holders · 66.78M shares
#1 FMR LLC 8.71M shares
#2 WELLINGTON MANAGEMENT GROUP LLP 7.12M shares
#3 Avoro Capital Advisors LLC 6.56M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest5.65M
Days to Cover7.3
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track GPCR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GPCR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GPCR
📊 GPCR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GPCR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.